Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Becker Drapkin Management Reduce Stake In Response Genetics Inc (RGDX)

Response Genetics, Inc. (NASDAQ:RGDX) has been trimmed in the equity portfolio of Matthew Drapkin and Steven R. Becker. According to a recently amended filing with the Securities and Exchange Commission, their fund, Becker Drapkin Management, has decreased its holding of the stock from 2.2 million to 1.53 million shares, which account for approximately 4% of the total number of shares outstanding.

Response Genetics, Inc. (NASDAQ:RGDX)

Response Genetics, Inc. (NASDAQ:RGDX) engages in the research and development of test for cancer. The company has a market cap of $44.9 million and does not pay a dividend. The stock has been trending sideways for some time now and is up 14% so far this year to a current price of $1.33 per share. Response Genetics has revealed revenues of $4.8 million, a 17% year-over-year increase, and a loss of $0.09 per share for the 2013 fourth quarter. Market participants expect the company to post revenues of $5.5 million and a loss per share of $0.05 for the current quarter.

Roberto Mignone has Response Genetics, Inc. (NASDAQ:RGDX) on his radar as his fund, Bridger Management, holds approximately 6 million shares valued at $6.96 million. Paul Ruddock and Steve Heinz are also keeping tabs with their fund, Lansdowne Partners, holding 3.8 million shares reportedly worth $4.41 million. Benjamin J Taylor, the manager of Sophrosyne Capital, has closed his fund’s position in this stock during the 2013 fourth quarter.

Another stock Drapkin and Becker have decided to limit exposure to is Pacer International, Inc. (NASDAQ:PACR). Becker Drapkin Management has dumped 2/3 of its holding of the stock and is left with approximately 746,800 shares or 1.8% of the company’s common stock. The fund has also dumped almost 90% of its stake in Pixelworks, Inc. (NASDAQ:PXLW) and is left holding 292,800 shares which account for 1.3% of the total number of shares outstanding.

Disclosure: none.

Recommended reading:

Becker Drapkin Management Further Reduces Holding in Pacer International, Inc. (PACR) to Under 2%

Becker Drapkin Management Cuts Its Stake in Pixelworks, Inc. (PXLW)

Becker Drapkin Management Increases Its Holding of Cascade Microtech, Inc. (CSCD)

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!